IDS Medical Systems Executive and Leadership Team

Benedict Chang, the Group Chief Executive Officer & Founding Partner at IDS Medical Systems, directs the overarching corporate strategy and operational framework for the company's medical supply chain solutions across Asia. Chang's leadership guides the organization's expansion initiatives and market positioning, ensuring alignment with the company's founding principles and future growth objectives. This executive role involves setting the vision for technological integration and service delivery improvements within the healthcare sector. Benedict Chang actively collaborates with regional leadership to optimize resource allocation and drive performance metrics. The focus remains on enhancing the efficiency and reliability of medical supply chains, directly impacting patient care and healthcare provider operations. Chang's strategic direction ensures the company maintains its competitive edge in a dynamic market.

Andrew Rahardja, the Chief Financial Officer & Vice President, Aesthetics, Biomedical Engineering & Consumables at IDS Medical Systems, manages the financial health and strategic fiscal planning for critical business segments. Rahardja oversees budgeting, forecasting, and financial reporting, ensuring robust fiscal discipline across the Aesthetics, Biomedical Engineering, and Consumables divisions. This dual role requires a deep understanding of both financial operations and the specific market dynamics of these product categories. Andrew Rahardja works to identify investment opportunities and manage financial risks, supporting the company's growth in specialized medical product areas. The executive's responsibilities extend to optimizing financial performance and resource deployment within these key operational units, contributing directly to IDS Medical Systems' overall profitability and market expansion.

Chuah Keng Yeong, the Chief Financial Officer & Executive Vice President at IDS Medical Systems, directs comprehensive financial strategies and oversees the fiscal operations of the entire organization. Keng Yeong's purview includes financial planning, capital management, and ensuring compliance with all regulatory financial standards across the Asian market. This executive leadership position is critical for maintaining the financial integrity and stability of IDS Medical Systems. Chuah Keng Yeong actively engages with stakeholders to secure funding and manage investor relations, driving financial performance and sustainable growth. The executive's strategic financial insights support operational decisions and long-term business development, ensuring the company's robust presence in the medical supply chain sector.

Rufi Susanto, the Group President at IDS Medical Systems, spearheads the operational execution and strategic initiatives across the company's regional presence in Asia. Susanto's leadership focuses on driving operational efficiency and expanding market penetration for medical supply chain solutions. This executive role involves overseeing day-to-day operations, ensuring seamless integration of services, and fostering strong relationships with key partners and clients. Rufi Susanto is instrumental in translating corporate strategy into actionable plans, managing cross-functional teams to achieve performance targets. The executive's focus on operational excellence directly supports IDS Medical Systems' mission to deliver reliable and advanced healthcare supply chain services throughout the region.